OmniAb, Inc.
NASDAQ:OABIBiotechnology
Healthcare
$5.08 +7.88%
+$0.16 today
- Market cap
- $740.97M
- Beta
- 1.15
- P/E (TTM)
- -5.2
- EPS (TTM)
- -$0.42
52W Low $1.30High $2.79
Volume 1.22M
Average 0.67M
Cash Flow
Check whether earnings turn into cash.
Operating Cash Flow
-$36.45M
FY 2025 · Annual
Investing Cash Flow
$6.47M
FY 2025 · Annual
-82.9% YoYFinancing Cash Flow
$27.91M
FY 2025 · Annual
+114.4% YoYCash Flow Statement
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (27.04M) | (22.33M) | (50.62M) | (62.03M) | (64.78M) |
| Depreciation & Amortization | 16.25M | 18.25M | 19.5M | 23.58M | 21.75M |
| Deferred Income Tax | (7.33M) | (6.42M) | (12.54M) | (9.04M) | (1.53M) |
| Stock-Based Compensation | 15.07M | 18.32M | 24.82M | 21.5M | 15.82M |
| Change in Working Capital | (2.63M) | (10.83M) | 24.87M | (10.17M) | (4.95M) |
| Accounts Receivables | 6.02M | (12.74M) | 26.9M | (625K) | 189K |
| Inventory | (1.51M) | 0 | 0 | 0 | 0 |
| Accounts Payables | 1.51M | 15.07M | 920K | (2.41M) | (231K) |
| Other Working Capital | (8.65M) | (13.16M) | (2.95M) | (7.14M) | (4.91M) |
| Other Non-Cash Items | 9K | (572K) | (3.68M) | (3.5M) | (4.3M) |
| Operating Cash Flow | (5.67M) | (3.59M) | 2.35M | (39.66M) | (36.46M) |
| Capital Expenditures | (4.07M) | (17.17M) | (1.64M) | (1.88M) | (565K) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | (54.78M) | (112.62M) | (40.29M) | (46.86M) |
| Sales of Investments | 1.27M | 70K | 100.32M | 80.45M | 50.89M |
| Other Investing Activities | (1.22M) | (1.44M) | (4.44M) | (400K) | 3M |
| Investing Cash Flow | (4.03M) | (73.31M) | (18.38M) | 37.88M | 6.47M |
| Debt Repayment | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued | 0 | 96.24M | 0 | 11.37M | 28.36M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 9.7M | 14.5M | (892K) | 1.65M | (450K) |
| Financing Cash Flow | 9.7M | 110.74M | (892K) | 13.02M | 27.91M |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 0 | 33.84M | (16.92M) | 11.24M | (2.07M) |
| Free Cash Flow | (9.74M) | (20.76M) | 703K | (41.54M) | (37.02M) |
Free Cash Flow
Net Income to FCF bridge
FY2025
= Net Income-$64.8M
+ D&A$21.8M
+ Stock-Based Comp$15.8M
- Deferred Tax-$1.5M
- Working Capital-$5.0M
- Other Non-Cash-$4.3M
= Operating Cash Flow-$36.5M
- Capex-$565.0K
= Free Cash Flow-$37.0M
Analysis
FY2025 free cash flow is -$37.0M. FCF conversion is 57.1% of net income. Operating cash flow was -$36.5M, with capex of -$565.0K. The largest bridge item is D&A at $21.8M.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership | Nov 2, 2026 | |
| 8-K | Current report | Oct 30, 2026 | |
| 10-Q | Quarterly report | Oct 30, 2026 | |
| SC 13G/A | SC 13G/A filing | Aug 14, 2026 | |
| 10-Q | Quarterly report | Aug 6, 2026 |
Does OABI generate free cash flow?
OmniAb, Inc. (OABI) generated -$37.02M of free cash flow in fiscal 2025.
How much operating cash flow does OABI produce?
Operating cash flow was -$36.45M, before capital expenditures of $565,000.00.
Continue the stock analysis
Jump to another research area for this company.